Table of Content

1 Study Coverage
1.1 Seasonal Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Seasonal Influenza Vaccines Revenue by Region
2.2.1 Global Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Seasonal Influenza Vaccines Revenue by Region (2018-2024)
2.2.3 Global Seasonal Influenza Vaccines Revenue by Region (2024-2029)
2.2.4 Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Seasonal Influenza Vaccines Sales by Region
2.4.1 Global Seasonal Influenza Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Seasonal Influenza Vaccines Sales by Region (2018-2024)
2.4.3 Global Seasonal Influenza Vaccines Sales by Region (2024-2029)
2.4.4 Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Seasonal Influenza Vaccines Sales by Manufacturers
3.1.1 Global Seasonal Influenza Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Seasonal Influenza Vaccines in 2022
3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2022
3.3 Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Seasonal Influenza Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Seasonal Influenza Vaccines Sales by Type
4.1.1 Global Seasonal Influenza Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Seasonal Influenza Vaccines Revenue by Type
4.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Seasonal Influenza Vaccines Price by Type
4.3.1 Global Seasonal Influenza Vaccines Price by Type (2018-2024)
4.3.2 Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Seasonal Influenza Vaccines Sales by Application
5.1.1 Global Seasonal Influenza Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Seasonal Influenza Vaccines Revenue by Application
5.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Seasonal Influenza Vaccines Price by Application
5.3.1 Global Seasonal Influenza Vaccines Price by Application (2018-2024)
5.3.2 Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Seasonal Influenza Vaccines Market Size by Type
6.1.1 US & Canada Seasonal Influenza Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Seasonal Influenza Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Seasonal Influenza Vaccines Market Size by Application
6.2.1 US & Canada Seasonal Influenza Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Seasonal Influenza Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Seasonal Influenza Vaccines Market Size by Country
6.3.1 US & Canada Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Seasonal Influenza Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Seasonal Influenza Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Market Size by Type
7.1.1 Europe Seasonal Influenza Vaccines Sales by Type (2018-2029)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Type (2018-2029)
7.2 Europe Seasonal Influenza Vaccines Market Size by Application
7.2.1 Europe Seasonal Influenza Vaccines Sales by Application (2018-2029)
7.2.2 Europe Seasonal Influenza Vaccines Revenue by Application (2018-2029)
7.3 Europe Seasonal Influenza Vaccines Market Size by Country
7.3.1 Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Seasonal Influenza Vaccines Sales by Country (2018-2029)
7.3.3 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Seasonal Influenza Vaccines Market Size
8.1.1 China Seasonal Influenza Vaccines Sales (2018-2029)
8.1.2 China Seasonal Influenza Vaccines Revenue (2018-2029)
8.2 China Seasonal Influenza Vaccines Market Size by Application
8.2.1 China Seasonal Influenza Vaccines Sales by Application (2018-2029)
8.2.2 China Seasonal Influenza Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Seasonal Influenza Vaccines Market Size by Type
9.1.1 Asia Seasonal Influenza Vaccines Sales by Type (2018-2029)
9.1.2 Asia Seasonal Influenza Vaccines Revenue by Type (2018-2029)
9.2 Asia Seasonal Influenza Vaccines Market Size by Application
9.2.1 Asia Seasonal Influenza Vaccines Sales by Application (2018-2029)
9.2.2 Asia Seasonal Influenza Vaccines Revenue by Application (2018-2029)
9.3 Asia Seasonal Influenza Vaccines Sales by Region
9.3.1 Asia Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Seasonal Influenza Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Seasonal Influenza Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline plc Recent Developments
11.2 Sinovac Biotech Ltd
11.2.1 Sinovac Biotech Ltd Company Information
11.2.2 Sinovac Biotech Ltd Overview
11.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sinovac Biotech Ltd Recent Developments
11.3 Changsheng Bio-Technology
11.3.1 Changsheng Bio-Technology Company Information
11.3.2 Changsheng Bio-Technology Overview
11.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Changsheng Bio-Technology Recent Developments
11.4 Ccbio SA
11.4.1 Ccbio SA Company Information
11.4.2 Ccbio SA Overview
11.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ccbio SA Recent Developments
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Company Information
11.5.2 Aleph Biomedical Overview
11.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aleph Biomedical Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Overview
11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
11.8 Dalian Hissen Bio-pharm
11.8.1 Dalian Hissen Bio-pharm Company Information
11.8.2 Dalian Hissen Bio-pharm Overview
11.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dalian Hissen Bio-pharm Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Information
11.9.2 Abbott Laboratories Overview
11.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Laboratories Recent Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Company Information
11.10.2 Novartis International AG Overview
11.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis International AG Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 AstraZeneca Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 EMERGEX VACCINES
11.12.1 EMERGEX VACCINES Company Information
11.12.2 EMERGEX VACCINES Overview
11.12.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EMERGEX VACCINES Recent Developments
11.13 SINOVAC
11.13.1 SINOVAC Company Information
11.13.2 SINOVAC Overview
11.13.3 SINOVAC Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 SINOVAC Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SINOVAC Recent Developments
11.14 Merck & Co., Inc.
11.14.1 Merck & Co., Inc. Company Information
11.14.2 Merck & Co., Inc. Overview
11.14.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Merck & Co., Inc. Recent Developments
11.15 Pfizer Inc
11.15.1 Pfizer Inc Company Information
11.15.2 Pfizer Inc Overview
11.15.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Pfizer Inc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pfizer Inc Recent Developments
11.16 Viatris Inc.
11.16.1 Viatris Inc. Company Information
11.16.2 Viatris Inc. Overview
11.16.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Viatris Inc. Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Viatris Inc. Recent Developments
11.17 Vaxess Technologies Inc
11.17.1 Vaxess Technologies Inc Company Information
11.17.2 Vaxess Technologies Inc Overview
11.17.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Vaxess Technologies Inc Recent Developments
11.18 OSIVAX
11.18.1 OSIVAX Company Information
11.18.2 OSIVAX Overview
11.18.3 OSIVAX Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 OSIVAX Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 OSIVAX Recent Developments
11.19 CSL Limited
11.19.1 CSL Limited Company Information
11.19.2 CSL Limited Overview
11.19.3 CSL Limited Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 CSL Limited Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 CSL Limited Recent Developments
11.20 EMERGENT
11.20.1 EMERGENT Company Information
11.20.2 EMERGENT Overview
11.20.3 EMERGENT Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 EMERGENT Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 EMERGENT Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Seasonal Influenza Vaccines Industry Chain Analysis
12.2 Seasonal Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Seasonal Influenza Vaccines Production Mode & Process
12.4 Seasonal Influenza Vaccines Sales and Marketing
12.4.1 Seasonal Influenza Vaccines Sales Channels
12.4.2 Seasonal Influenza Vaccines Distributors
12.5 Seasonal Influenza Vaccines Customers
13 Market Dynamics
13.1 Seasonal Influenza Vaccines Industry Trends
13.2 Seasonal Influenza Vaccines Market Drivers
13.3 Seasonal Influenza Vaccines Market Challenges
13.4 Seasonal Influenza Vaccines Market Restraints
14 Key Findings in The Global Seasonal Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type A (H1N1)
Table 3. Major Manufacturers of Type A (H3N2)
Table 4. Major Manufacturers of Type B
Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2024)
Table 10. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 11. Global Seasonal Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Seasonal Influenza Vaccines Sales by Region (2018-2024) & (K Units)
Table 13. Global Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 14. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2024)
Table 15. Global Seasonal Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 16. Global Seasonal Influenza Vaccines Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2018-2024)
Table 18. Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Seasonal Influenza Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
Table 24. Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 29. Global Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 30. Global Seasonal Influenza Vaccines Sales Share by Type (2018-2024)
Table 31. Global Seasonal Influenza Vaccines Sales Share by Type (2024-2029)
Table 32. Global Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Seasonal Influenza Vaccines Revenue Share by Type (2018-2024)
Table 35. Global Seasonal Influenza Vaccines Revenue Share by Type (2024-2029)
Table 36. Seasonal Influenza Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 39. Global Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 40. Global Seasonal Influenza Vaccines Sales Share by Application (2018-2024)
Table 41. Global Seasonal Influenza Vaccines Sales Share by Application (2024-2029)
Table 42. Global Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Seasonal Influenza Vaccines Revenue Share by Application (2018-2024)
Table 45. Global Seasonal Influenza Vaccines Revenue Share by Application (2024-2029)
Table 46. Seasonal Influenza Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 61. Europe Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 62. Europe Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 63. Europe Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 66. Europe Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 67. Europe Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 73. Europe Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 74. China Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 75. China Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 76. China Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 79. China Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 80. China Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 83. Asia Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 84. Asia Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 87. Asia Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 88. Asia Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Seasonal Influenza Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Seasonal Influenza Vaccines Sales by Region (2018-2024) & (K Units)
Table 94. Asia Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 108. GlaxoSmithKline plc Company Information
Table 109. GlaxoSmithKline plc Description and Major Businesses
Table 110. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline plc Recent Developments
Table 113. Sinovac Biotech Ltd Company Information
Table 114. Sinovac Biotech Ltd Description and Major Businesses
Table 115. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sinovac Biotech Ltd Recent Developments
Table 118. Changsheng Bio-Technology Company Information
Table 119. Changsheng Bio-Technology Description and Major Businesses
Table 120. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Changsheng Bio-Technology Recent Developments
Table 123. Ccbio SA Company Information
Table 124. Ccbio SA Description and Major Businesses
Table 125. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Ccbio SA Recent Developments
Table 128. Aleph Biomedical Company Information
Table 129. Aleph Biomedical Description and Major Businesses
Table 130. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Aleph Biomedical Recent Developments
Table 133. Sanofi Company Information
Table 134. Sanofi Description and Major Businesses
Table 135. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sanofi Recent Developments
Table 138. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
Table 139. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Major Businesses
Table 140. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
Table 143. Dalian Hissen Bio-pharm Company Information
Table 144. Dalian Hissen Bio-pharm Description and Major Businesses
Table 145. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Dalian Hissen Bio-pharm Recent Developments
Table 148. Abbott Laboratories Company Information
Table 149. Abbott Laboratories Description and Major Businesses
Table 150. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Abbott Laboratories Recent Developments
Table 153. Novartis International AG Company Information
Table 154. Novartis International AG Description and Major Businesses
Table 155. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Novartis International AG Recent Developments
Table 158. AstraZeneca Company Information
Table 159. AstraZeneca Description and Major Businesses
Table 160. AstraZeneca Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. AstraZeneca Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. AstraZeneca Recent Developments
Table 163. EMERGEX VACCINES Company Information
Table 164. EMERGEX VACCINES Description and Major Businesses
Table 165. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. EMERGEX VACCINES Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. EMERGEX VACCINES Recent Developments
Table 168. SINOVAC Company Information
Table 169. SINOVAC Description and Major Businesses
Table 170. SINOVAC Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. SINOVAC Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. SINOVAC Recent Developments
Table 173. Merck & Co., Inc. Company Information
Table 174. Merck & Co., Inc. Description and Major Businesses
Table 175. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Merck & Co., Inc. Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Merck & Co., Inc. Recent Developments
Table 178. Pfizer Inc Company Information
Table 179. Pfizer Inc Description and Major Businesses
Table 180. Pfizer Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Pfizer Inc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Pfizer Inc Recent Developments
Table 183. Viatris Inc. Company Information
Table 184. Viatris Inc. Description and Major Businesses
Table 185. Viatris Inc. Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Viatris Inc. Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Viatris Inc. Recent Developments
Table 188. Vaxess Technologies Inc Company Information
Table 189. Vaxess Technologies Inc Description and Major Businesses
Table 190. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Vaxess Technologies Inc Recent Developments
Table 193. OSIVAX Company Information
Table 194. OSIVAX Description and Major Businesses
Table 195. OSIVAX Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. OSIVAX Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. OSIVAX Recent Developments
Table 198. CSL Limited Company Information
Table 199. CSL Limited Description and Major Businesses
Table 200. CSL Limited Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. CSL Limited Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. CSL Limited Recent Developments
Table 203. EMERGENT Company Information
Table 204. EMERGENT Description and Major Businesses
Table 205. EMERGENT Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. EMERGENT Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. EMERGENT Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Seasonal Influenza Vaccines Distributors List
Table 211. Seasonal Influenza Vaccines Customers List
Table 212. Seasonal Influenza Vaccines Market Trends
Table 213. Seasonal Influenza Vaccines Market Drivers
Table 214. Seasonal Influenza Vaccines Market Challenges
Table 215. Seasonal Influenza Vaccines Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Picture
Figure 2. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Type A (H1N1) Product Picture
Figure 5. Type A (H3N2) Product Picture
Figure 6. Type B Product Picture
Figure 7. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 9. Pediatrics
Figure 10. Adolescence
Figure 11. Adults
Figure 12. Elderly
Figure 13. Seasonal Influenza Vaccines Report Years Considered
Figure 14. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Seasonal Influenza Vaccines Revenue 2018-2029 (US$ Million)
Figure 16. Global Seasonal Influenza Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2029)
Figure 18. Global Seasonal Influenza Vaccines Sales 2018-2029 ((K Units)
Figure 19. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 25. China Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Seasonal Influenza Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Seasonal Influenza Vaccines in the World: Market Share by Seasonal Influenza Vaccines Revenue in 2022
Figure 32. Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 34. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 35. Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 36. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Seasonal Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 42. US & Canada Seasonal Influenza Vaccines Sales Share by Country (2018-2029)
Figure 43. U.S. Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 46. Europe Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 47. Europe Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 48. Europe Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 49. Europe Seasonal Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 50. Europe Seasonal Influenza Vaccines Sales Share by Country (2018-2029)
Figure 51. Germany Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. France Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 56. China Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 57. China Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 58. China Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 59. China Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 60. Asia Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 61. Asia Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 62. Asia Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 63. Asia Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 64. Asia Seasonal Influenza Vaccines Revenue Share by Region (2018-2029)
Figure 65. Asia Seasonal Influenza Vaccines Sales Share by Region (2018-2029)
Figure 66. Japan Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 70. India Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales Share by Country (2018-2029)
Figure 77. Brazil Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Seasonal Influenza Vaccines Revenue (2018-2029) & (US$ Million)
Figure 82. Seasonal Influenza Vaccines Value Chain
Figure 83. Seasonal Influenza Vaccines Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed